These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28099818)

  • 1. Intraperitoneal chemotherapy and cytoreductive surgery for peritoneal metastases coupled with curative treatment of colorectal liver metastases: an updated systematic review.
    El-Nakeep S; Rashad N; Oweira H; Schmidt J; Helbling D; Giryes A; Petrausch U; Mehrabi A; Decker M; Abdel-Rahman O
    Expert Rev Gastroenterol Hepatol; 2017 Mar; 11(3):249-258. PubMed ID: 28099818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: Systematic review of all literature and meta-analysis of observational studies.
    de Cuba EM; Kwakman R; Knol DL; Bonjer HJ; Meijer GA; Te Velde EA
    Cancer Treat Rev; 2013 Jun; 39(4):321-7. PubMed ID: 23244778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal metastases.
    Mirnezami R; Moran BJ; Harvey K; Cecil T; Chandrakumaran K; Carr N; Mohamed F; Mirnezami AH
    World J Gastroenterol; 2014 Oct; 20(38):14018-32. PubMed ID: 25320542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synchronous Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Liver and Peritoneal Metastases: A Systematic Review and Meta-analysis.
    Flood MP; Das AA; Soucisse ML; Kong J; Ramsay RG; Michael M; Loveday BPT; Warrier SK; Heriot AG
    Dis Colon Rectum; 2021 Jun; 64(6):754-764. PubMed ID: 33742615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal and extraperitoneal relapse after previous curative treatment of peritoneal metastases from colorectal cancer: What survival can we expect?
    Gelli M; Huguenin JFL; de Baere T; Benhaim L; Mariani A; Boige V; Malka D; Sourouille I; Ducreux M; Elias D; Goéré D
    Eur J Cancer; 2018 Sep; 100():94-103. PubMed ID: 30014885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
    Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical Treatment of Colorectal Cancer with Peritoneal and Liver Metastases Using Combined Liver and Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Report from a Single-Centre Experience.
    Navez J; Remue C; Leonard D; Bachmann R; Kartheuser A; Hubert C; Coubeau L; Komuta M; Van den Eynde M; Zech F; Jabbour N
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):666-673. PubMed ID: 27646023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synchronous liver metastases and peritoneal carcinomatosis from colorectal cancer: different strategies for curative treatment?
    Pinto A; Hobeika C; Philis A; Kirzin S; Carrère N; Ghouti L
    Langenbecks Arch Surg; 2019 Jun; 404(4):477-488. PubMed ID: 31025165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy combined with liver resection for concurrent peritoneal and hepatic metastases of gastrointestinal and gynecological primary tumors.
    Horvath P; Beckert S; Königsrainer A; Nadalin S; Königsrainer I
    J Visc Surg; 2019 Dec; 156(6):475-484. PubMed ID: 31324533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curative cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis and synchronous resectable liver metastases arising from colorectal cancer.
    Lorimier G; Linot B; Paillocher N; Dupoiron D; Verrièle V; Wernert R; Hamy A; Capitain O
    Eur J Surg Oncol; 2017 Jan; 43(1):150-158. PubMed ID: 27839895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoreductive surgery (CR) followed by hyperthermic intraperitoneal chemotherapy (HIPEC): a chance of survival for patients with advanced colorectal cancer.
    Bartoş A; Bartoş DM; Breazu C; Hosu M; Stoian R; Iancu C
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):392-3. PubMed ID: 26405715
    [No Abstract]   [Full Text] [Related]  

  • 12. Incidence and treatment of recurrent disease after cytoreductive surgery and intraperitoneal chemotherapy for peritoneally metastasized colorectal cancer: A systematic review.
    van Oudheusden TR; Nienhuijs SW; Luyer MD; Nieuwenhuijzen GA; Lemmens VE; Rutten HJ; de Hingh IH
    Eur J Surg Oncol; 2015 Oct; 41(10):1269-77. PubMed ID: 26175345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Neoadjuvant and Adjuvant Systemic Chemotherapy with Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Systematic Review.
    Waite K; Youssef H
    Ann Surg Oncol; 2017 Mar; 24(3):705-720. PubMed ID: 28058545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal-Free Cancer Cells Represent a Major Prognostic Factor in Colorectal Peritoneal Carcinomatosis.
    Trilling B; Cotte E; Vaudoyer D; Isaac S; Piaton E; Maurice C; Glehen O; Passot G
    Dis Colon Rectum; 2016 Jul; 59(7):615-22. PubMed ID: 27270513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should a History of Extraperitoneal Disease Be a Contraindication to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Metastases?
    Baratti D; Kusamura S; Iusco D; Cotsoglou C; Guaglio M; Battaglia L; Virzì S; Mazzaferro V; Deraco M
    Dis Colon Rectum; 2018 Sep; 61(9):1026-1034. PubMed ID: 30086051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection.
    Chua TC; Yan TD; Zhao J; Morris DL
    Eur J Surg Oncol; 2009 Dec; 35(12):1299-305. PubMed ID: 19632081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal carcinomatosis with synchronous liver metastases from colorectal cancer: Who will benefit from complete cytoreductive surgery?
    Delhorme JB; Dupont-Kazma L; Addeo P; Lefebvre F; Triki E; Romain B; Meyer N; Bachellier P; Rohr S; Brigand C
    Int J Surg; 2016 Jan; 25():98-105. PubMed ID: 26607853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemotherapy with bevacizumab may improve outcome after cytoreduction and hyperthermic intraperitoneal chemoperfusion (HIPEC) for colorectal carcinomatosis.
    Ceelen W; Van Nieuwenhove Y; Putte DV; Pattyn P
    Ann Surg Oncol; 2014 Sep; 21(9):3023-8. PubMed ID: 24756812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression following neoadjuvant systemic chemotherapy may not be a contraindication to a curative approach for colorectal carcinomatosis.
    Passot G; Vaudoyer D; Cotte E; You B; Isaac S; Noël Gilly F; Mohamed F; Glehen O
    Ann Surg; 2012 Jul; 256(1):125-9. PubMed ID: 22580942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The European contribution to "Sugarbaker's protocol" for the treatment of colorectal peritoneal carcinomatosis.
    Gómez Portilla A; Cendoya I; Olabarría I; Martínez de Lecea C; Gómez Martínez de Lecea C; Gil A; Martín E; Muriel J; Magrach L; Romero E; Lirola A; Guede N; Moraza N; Fernández E; Kvadatze M; Valdovinos M; Larrabide I; Ruiz de Alegría N; Fernández JL; Castillo C; Rua O; Ulibarrena MA
    Rev Esp Enferm Dig; 2009 Feb; 101(2):97-102, 103-6. PubMed ID: 19335045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.